Get started
Award

Health-2009-242-210

Funded outputs count: 9
Funder award ID: HEALTH-2009-242-210
OpenAlex ID: G3851346909
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies
2026 · Adrian Gervais, Astrid Marchal, et al. · Proceedings of the National Academy of Sciences
PDF
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies
2026 · Adrian Gervais, Astrid Marchal, et al. · medRxiv
Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis
2023 · José A. Villegas, Jérôme Van Wassenhove, et al. · Journal of Neuroinflammation · 11
PDF
MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance
2020 · Debby Reuveni, Revital Aricha, et al. · Frontiers in Immunology · 9
PDF
Cultured Human Thymic-Derived Cells Display Medullary Thymic Epithelial Cell Phenotype and Functionality
2018 · José A. Villegas, Angeline Gradolatto, et al. · Frontiers in Immunology · 21
PDF
AIRE: a missing link to explain female susceptibility to autoimmune diseases
2017 · Sonia Berrih‐Aknin, Rozen Le Panse, et al. · Annals of the New York Academy of Sciences · 23
Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?
2017 · Paola Cavalcante, Stefania Marcuzzo, et al. · Oncotarget · 42
PDF
Etiology of myasthenia gravis: Innate immunity signature in pathological thymus
2013 · Paola Cavalcante, Perrine Cufi, et al. · Autoimmunity Reviews · 99
A New Thiopurine S‐Methyltransferase Haplotype Associated With Intolerance to Azathioprine
2012 · Lara Colleoni, Dimos Kapetis, et al. · The Journal of Clinical Pharmacology · 24
PDF
Year
Topic